Loop Genomics Overview

  • Founded

  • 2015

Founded
  • Status

  • Acquired/​Merged

  • Employees

  • 7

Employees
  • Latest Deal Type

  • M&A

Loop Genomics General Information

Description

Developer of a long-read DNA sequencing technology designed to provide genomics tools that bring clarity to genetic data. The company's technology encompasses consumables and analysis tools that are intended to address a wide range of genetic analysis services for research, diagnostics, ag-bio, and industrial applications, enabling clients to avail of long-read sequencing and single-molecule counting by using a lab's existing sequencing hardware.

Contact Information

Website
www.loopgenomics.com
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Medical Supplies
Other Industries
Other Healthcare Services
Biotechnology
Acquirer
Element Biosciences
Primary Office
  • 5941 Optical Court
  • San Jose, CA 95138
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Loop Genomics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 08-Feb-2022 000.00 Completed Generating Revenue
5. Secondary Transaction - Private 01-Nov-2020 000.00 Completed Generating Revenue
4. Early Stage VC (Series A) 14-Feb-2018 00.00 000.00 000.00 Completed Generating Revenue
3. Accelerator/Incubator 00.000 Completed Startup
2. Early Stage VC 20-May-2016 $1.5M $1.62M Completed Startup
1. Accelerator/Incubator 23-Mar-2016 $120K $120K 00.000 Completed Startup
To view Loop Genomics’s complete valuation and funding history, request access »

Loop Genomics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate ($) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A-4 000,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-3 00,000 00.000000 00.00 00.00 00.00 00 00.00 0.000
Series A-2 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.00
Series A-1 1,214,181 $0.000010 $0.03 $0.41 $0.41 1x $0.41 5.21%
Series A 6,861,063 $0.000010 $0.09 $1.17 $1.17 1x $1.17 24.88%
To view Loop Genomics’s complete cap table history, request access »

Loop Genomics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a long-read DNA sequencing technology designed to provide genomics tools that bring clarity to genetic data
Medical Supplies
San Jose, CA
7 As of 2022
000.00
000000&0 000.00

000000

elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim
0000000000000
South Plainfield, NJ
000 As of 0000
0000 0000-00-00
000000&0

00 000

uis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat
0000000000000
Shirley, NY
0 As of 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Loop Genomics Competitors (28)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genewiz Formerly VC-backed South Plainfield, NJ 000 000000&0
00 00000000 Corporation Shirley, NY 0
0000000 Private Equity-Backed Woburn, MA 000 000.00 000000000000 000.00
000000000 Formerly VC-backed Seraing, Belgium 000 00.000 000000&0 00.000
000000 00000 Private Equity-Backed Carlsbad, CA 000 0000000 0000
You’re viewing 5 of 28 competitors. Get the full list »

Loop Genomics Patents

  • 12

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 1

    Granted

  • 1

    Pending

  • 000

    Expiring in next 12 mo

Loop Genomics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3665280-A4 Tagging nucleic acid molecules from single cells for phased sequencing Pending 10-Aug-2017 00000000000 0
EP-3665280-A2 Tagging nucleic acid molecules from single cells for phased sequencing Pending 10-Aug-2017 00000000000
GB-2581599-A Tagging nucleic acid molecules from single cells for phased sequencing Pending 10-Aug-2017 00000000000
GB-202004670-D0 Tagging nucleic acid molecules from single cells for phased sequencing Pending 10-Aug-2017 00000000000
US-20200231964-A1 Tagging nucleic acid molecules from single cells for phased sequencing Inactive 10-Aug-2017 C12N15/1065
To view Loop Genomics’s complete patent history, request access »

Loop Genomics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Loop Genomics Former Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
11.2 Capital Venture Capital Minority 000 0000 000000 0
DN Capital Venture Capital Minority 000 0000 000000 0
Foothill Ventures Venture Capital Minority 000 0000 000000 0
Fusion Fund Venture Capital Minority 000 0000 000000 0
Khosla Ventures Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »

Ready to get started?

Request a free trial